Search
for
Sort by
Research 661–690 of 1000+
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Distribution of Body Hair in Young Australian Women and Associations With Serum Androgen Concentrations
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
- Alopecia areata – Current understanding and management
- Epidemiology of Vitiligo – A Dual Population-Based Approach
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study
- Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Use of topical clascoterone for the treatment of hidradenitis suppurativa
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Human iPS Cell-Derived Cell Aggregates Exhibited Dermal Papilla Cell Properties in in vitro Three-Dimensional Assemblage Mimicking Hair Follicle Structures
- ‘Dr. Google, What Is That on My Skin?’—Internet Searches Related to Skin Problems: Google Trends Data from 2004 to 2019
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Bibliometric evaluation of Anais Brasileiros de Dermatologia (2013-2022)
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives
- Factors influencing alopecia areata treatment decisions: A qualitative assessment
- Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Progress in Lipid and Inorganic Nanocarriers for Enhanced Skin Drug Delivery
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)